CRVS: financial statements from SEC

Income statement

Metric	31/03/2026	30/09/2025	30/06/2025	31/03/2025	30/09/2024	30/06/2024
Research and development	11M	8M	8M	7M	5M	4M
Selling, general and administrative	4M	2M	2M	2M	2M	2M
Operating expenses	15M	11M	10M	10M	7M	6M
Operating income	−15M	−11M	−10M	−10M	−7M	−6M
Pre-tax income	−13M	−10M	−8M	16M	−40M	−4M
Net income	−14M	−10M	−8M	15M	−40M	−4M
Earnings per share	−0.15	−0.12	−0.10	0.21	−0.60	−0.07
Earnings per share, diluted	−0.15	−0.12	−0.10	−0.13	−0.60	−0.07
Weighted average shares	90M	83M	78M	72M	67M	60M
Weighted average shares, diluted	90M	83M	78M	75M	67M	60M

Metric	31/03/2026	31/12/2025	30/09/2025	30/06/2025	31/03/2025	31/12/2024	30/09/2024	30/06/2024
Cash and equivalents	40M	5M	3M	15M	5M	9M	5M	15M
Receivables	43,000	37,000	32,000	86,000	79,000	75,000	70,000	35,000
Current assets	240M	58M	67M	76M	45M	54M	43M	48M
Property, plant and equipment	282,000	220,000	221,000	249,000	165,000	151,000	171,000	192,000
Total assets	253M	71M	80M	89M	59M	69M	59M	65M
Current liabilities	12M	9M	8M	9M	9M	35M	46M	13M
Total liabilities	13M	10M	9M	9M	10M	36M	46M	13M
Equity	241M	61M	72M	80M	49M	33M	12M	51M
Shares outstanding	84M	75M	75M	75M	68M	68M	63M	63M
Shares issued	84M	75M	75M	75M	68M	68M	63M	63M

Metric	31/03/2026	31/03/2025
Operating cash flow	−10M	−8M
Depreciation and amortisation	29,000	22,000
Share-based compensation	3M	1M
Capital expenditure	91,000	36,000
Investing cash flow	−145M	4M
Financing cash flow	191M	279,000